← Back to All Filings

Opus Genetics CEO Disposes of $70k in Stock for Tax Withholding

Low SignificanceNovember 4, 2025 at 4:35:00 PM EST

Opus Genetics, Inc.

$IRD4CIK: 0001228627

Subscribe to track IRD

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Opus Genetics CEO Disposes of $70k in Stock for Tax Withholding

Company: Opus Genetics, Inc. (IRD) Form: 4 | Filed: 2025-11-04 Significance: Low

Insider: Magrath George Title: Chief Executive Officer | Relationship: Director, Officer

Transaction: • Type: Tax Withholding • Shares: 30,350 • Price: $2.30 • Value: $69,805 • Owned After: 1,291,654

Key Insight: This is a non-discretionary sale to cover tax liabilities, not an active trading decision by the CEO. It holds minimal informational value regarding insider sentiment.

Market Context: The transaction represents less than 0.1% of the company's market cap and shares outstanding, making it immaterial.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Opus Genetics, Inc. (IRD)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: The CEO disposed of shares in a non-discretionary transaction to cover tax obligations, which is a routine event with no bearing on insider sentiment.
  • Market Impact: Negligible, as the transaction is immaterial relative to the company's market capitalization and public float.

Company Information

FieldValue
CompanyOpus Genetics, Inc.
Ticker SymbolIRD
CIK0001228627
IndustryPHARMACEUTICAL PREPARATIONS

Insider Information

FieldValue
NameMagrath George
CIK0001999390
Title/PositionChief Executive Officer
RelationshipDirector, Officer

Transaction Details

FieldValue
Form Type4
Transaction Date2025-11-01
Transaction CodeF - Payment of tax liability by withholding security
Security TypeCommon Stock
Shares Involved30,350
Price Per Share$2.3
Total Value$69,805
Shares Owned After1,291,654
Ownership TypeDirect

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$69,805
% of Market Cap0.05%
Shares Transacted30,350
% of Shares Outstanding0.05%
Post-Transaction Ownership1,291,654 shares (2.16% of outstanding)
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: For a company with a market capitalization of $140 million, this $69,805 transaction is financially insignificant.
  • Ownership Concentration: The CEO's post-transaction ownership of 2.16% remains a notable stake, but this specific transaction does not materially alter it.
  • Transaction Significance: The transaction is classified as 'Low' significance. Both its value relative to market cap (0.05%) and shares relative to outstanding shares (0.05%) are well below the thresholds for moderate or high significance. The 'F' code confirms it is a non-market, tax-related disposition.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: Transactions coded 'F' are automatic sales to cover taxes on vested equity awards. They do not reflect an insider's voluntary decision to sell and are typically disregarded by the market.

Volume & Sentiment

  • Expected Volume Impact: None. This is a withholding of shares and not an open market sale.
  • Sentiment Indicator: Neutral. The filing provides no new information about the insider's outlook on the company's future performance.

Additional Context

Transaction Notes

  • Special Circumstances: The transaction code 'F' explicitly denotes a disposition of shares to the issuer to satisfy tax withholding obligations upon the vesting of restricted stock units or similar equity awards. This is a common and non-indicative event.
Topics:#SECFiling#InsiderTrading#IRD#OpusGenetics#Form4#StockMarket#CEOTransaction#LowSignificance

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.